{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5c322849e168793762158038/60863e4dcfb9e813fa7a62e9?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The Comeback of Psychedelics for the Treatment of Depression?","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5c322849e168793762158038/1619410666918-7531fe35de8679d0f33fcb2fa0c3d1f8.jpeg?height=200","description":"<p>Today in Episode 102, I share some scientific evidence on psychedelics or hallucinogens in the context of mood disorders and mental health. In the 1960s and 1970s, a psychedelic, LSD, was studied for its ability to improve mood in patients diagnosed with a terminal illness. However, regulatory laws stopped this type of research until recently when it was granted a status of Breakthrough Therapy Designation allowing it to be studied in clinical populations again. Are there benefits in depression and anxiety? Tune in to find out!</p><p><br></p><p>Want to buy me a coffee to say thanks for the episode? You can do so via Venmo or Patreon below.</p><p>Venmo ID: Steph-Cal</p><p>Patreon: https://www.patreon.com/join/DrSCaligiuri</p><p><br></p><p>Follow me on social media to see the papers I cite in this week's episode:</p><p>IG: Dr.SCaligiuri</p><p>FB: ThePeoplesScientist</p><p>Twitter: DrSCaligiuri</p><p>Linkedin: Stephanie Caligiuri</p><p>TikTok: Dr.SCaligiuri</p>","author_name":"Dr. Stephanie Caligiuri"}